NatWest (NWG) Q2 2026 Earnings Call Transcript

NatWest Group reported Q2 2026 income (ex-notable items) of GBP 4.4B (+5.4% vs Q1), with operating profit of GBP 2.3B (+12.4%) and a return on tangible equity of 21% (ROTE up from 19.7%). Management upgraded 2026 guidance to ~GBP 17.9B income (ex-notable items) and now expects capital generation before distributions (including Evelyn Partners) of >240 bps, while keeping credit impairment contained at GBP 140M (~13 bps of loans). The CET1 ratio was 13.2% at quarter-end and liquidity remains strong (LCR 140%, ~GBP 44B surplus primary liquidity); the bank also reiterated that the next share buyback announcement will come with full-year results in Feb 2027.

Analysis

NWG is a relative-quality beneficiary inside UK financials: the combination of high capital conversion, low credit cost, and organic balance-sheet growth supports a higher sustainable payout capacity than peers that are either more rate-sensitive or more market-beta driven. The second-order effect is not just higher equity returns; it also improves wholesale funding terms and should keep senior/covered bond spreads tighter than weaker UK names, while making NWG a more attractive core issuer for liability managers.

The key risk is timing, not direction. The immediate catalyst is the market’s reaction to the upgraded capital/income outlook, but the next 1-3 months matter more for H2 issuance cadence, buyback signaling, and whether deposit/lending growth remains clean into a softer UK macro backdrop. Over 6-18 months, Basel 3.1 remains the main drag: even if leverage reforms look supportive, risk-weighted assets are still the binding constraint, so buyback math can decelerate before it accelerates.

Contrarianly, the consensus may be overpricing regulatory upside and underpricing execution risk on the wealth acquisition integration and mortgage margin normalization. The better read is that NWG has earned a modest rerating on fundamentals, but the bigger upside case is relative performance versus other UK banks, not an absolute multiple revaluation. What would falsify the thesis: CET1 drifting below the low-13s ex-distributions, impairments moving above 25 bps, or any evidence that deposit beta / funding costs are rising faster than asset yields.

Key Decisions for Investors

• Long NWG equity on any post-print consolidation over the next 1-2 weeks; target a 8-12% relative upside if H2 capital generation stays >240 bps and buyback guidance is reaffirmed in February, with thesis invalidated by a CET1 ratio trend toward 13.0% before distributions.
• Pair trade: long NWG / short BARC for 1-3 months to express quality + capital conversion vs higher earnings volatility and more cyclical balance-sheet sensitivity; keep the spread on if NWG continues to outperform on operating leverage and deposit growth.
• Add to NWG on any pullback tied to macro fears rather than bank-specific deterioration; this is a fundamentals-led trade, and the risk/reward improves if the market waits for regulatory clarity before rerating the stock.
• For credit-focused accounts, prefer NWG senior/covered bond exposure over weaker UK bank paper into H2 issuance; tighter spreads are justified unless funding costs widen materially or the bank becomes a heavier issuer than expected.
• Set a watch item for Basel 3.1 / PRA domestic-capital reform in Q4: if the PRA signals meaningful simplification beyond leverage optics, add to NWG and the broader UK bank basket; if not, treat the current move as mostly already earned.